Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.03)
# 534
Out of 5,147 analysts
352
Total ratings
41.71%
Success rate
15.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $29.84 | +67.56% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $4.31 | +178.42% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $332.92 | +71.21% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $6.90 | +479.71% | 17 | Aug 4, 2025 | |
| ATAI AtaiBeckley | Maintains: Buy | $10 → $15 | $3.63 | +313.22% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $19.69 | -49.21% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.69 | +195.86% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.43 | +2,213.21% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.44 | +1,278.68% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $32.30 | +209.60% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $15.63 | +347.86% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.13 | +342.48% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.20 | +1,328.57% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $63.27 | +26.44% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $14.85 | +169.36% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.10 | +631.71% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $28.54 | +145.27% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $28.46 | +181.10% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.71 | +484.80% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.42 | +2,253.49% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $9.09 | +1,110.12% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $83.82 | +1.41% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $10.90 | +523.85% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $72.64 | +368.06% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $29.84
Upside: +67.56%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $4.31
Upside: +178.42%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $332.92
Upside: +71.21%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $6.90
Upside: +479.71%
AtaiBeckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $3.63
Upside: +313.22%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $19.69
Upside: -49.21%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.69
Upside: +195.86%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.43
Upside: +2,213.21%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $5.44
Upside: +1,278.68%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $32.30
Upside: +209.60%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $15.63
Upside: +347.86%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.13
Upside: +342.48%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.20
Upside: +1,328.57%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $63.27
Upside: +26.44%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $14.85
Upside: +169.36%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.10
Upside: +631.71%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $28.54
Upside: +145.27%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $28.46
Upside: +181.10%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.71
Upside: +484.80%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.42
Upside: +2,253.49%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $9.09
Upside: +1,110.12%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $83.82
Upside: +1.41%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $10.90
Upside: +523.85%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $72.64
Upside: +368.06%